Combating the symptoms of menopauseThe good news is that women today can reasonably expect to live into their 90s. The bad news is that women today can reasonably expect to live to be in their 90s. Bad news, that is, without some help along the way to deal with the stresses, strains, and realities of growing older. For women in their 40s and 50s, the onset of menopause can be a troubling time. Many women go through it without a lot of problems. For others, however, menopause can be an awful experience. Menopause is that time in mid-life when hormone levels begin to decrease and the menses cease. What sometimes accompanies this change are hot flashes, night sweats, and mood swings. There is also the concern of bone loss, caused in part by a lack of estrogen, one of the hormones linked to the menstrual cycle. Estrogen and progesterone have an active role in the menstrual cycle. When their production is not in balance due to changes in the ovaries and glands that produce the hormones, too much of one or the other may be produced. What generally results is referred to as estrogen dominance; that is, too much estrogen compared to progesterone. AIM RevitaFem® a natural, botanical supplement that, combined with regular exercise, management of stress, a whole foods diet, and elimination of toxins, combats the symptoms of menopause. AIM RevitaFem® contains eight botanical ingredients, all contributing unique properties to help control excess estrogen and assist in regulating and balancing body systems. In general, a natural ingredient in the product, called phytoestrogens, modulates and helps regulate out-of-balance estrogen levels. AIM RevitaFem® is a natural alternative to hormone replacement therapy (HRT), which emerged in the 1960s to treat the symptoms of menopause as well as a number of other conditions including depression, cardiovascular disease, and bone loss. While HRT was found to be effective, research has found a number of health concerns that accompany it including blood clots, stroke, coronary heart disease, and breast cancer. |